Purple Biotech Ltd. (NASDAQ: PPBT)
$2.1800
-0.0100 ( -0.46% ) 0.1K
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Market Data
Open
$2.1800
Previous close
$2.1900
Volume
0.1K
Market cap
$3.43M
Day range
$2.1900 - $2.4490
52 week range
$2.0000 - $23.2000
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 6-k | Form 6-K | 2 | Nov 15, 2024 |
| 6-k | Form 6-K | 2 | Nov 04, 2024 |
| 6-k | Form 6-K | 2 | Oct 25, 2024 |
| 6-k | Form 6-K | 2 | Oct 10, 2024 |
| 6-k | Form 6-K | 56 | Oct 09, 2024 |
| 6-k | Form 6-K | 1 | Oct 02, 2024 |
| 6-k | Form 6-K | 2 | Sep 18, 2024 |
| 6-k | Form 6-K | 1 | Sep 11, 2024 |
| 6-k | Form 6-K | 55 | Aug 19, 2024 |
| 6-k | Form 6-K | 3 | Aug 16, 2024 |